As Chief Commercial Officer and Executive Vice President of Ventures at MedAxiom, Joe helps members access technologies and solutions to effectively run their organizations and prepare for the future of value-based care. A tenured member of the MedAxiom team, Joe brings a wide variety of perspectives on healthcare operations and market access strategies to his work with companies spanning MedTech, device, pharma, imaging, cath labs/ambulatory surgery centers (ASCs) and health IT spaces, delivering economic value propositions and strategies to accelerate commercial growth.
As the leader of MedAxiom Ventures, Joe works to commercialize MedAxiom’s product portfolio with a focus on innovation, commercial acceleration, and operational execution for over 40 companies in the cardiovascular arena. He spearheaded the development of the HeartX Accelerator, which invests in and accelerates growth-stage companies. He was also responsible for the creation and execution of MedAxiom’s joint venture with Atlas Healthcare Partners, positioning MedAxiom as a leader in the ASC space for both clinical quality and operational efficiency. Joe has also led MedAxiom’s initiatives in the direct contracting space, aiming to link self-funded insurers with high-quality cardiovascular providers across the nation to create steerage that simultaneously improves outcomes for patients and lowers costs for payers.
Over the course of his career, Joe has advised over 100 companies – from small startups to the largest names in cardiovascular care – on commercial strategy, sales execution, risk model creation, market segmentation, and care pathway development with a focus on commercialization. His experience has provided him with valuable expertise spanning numerous aspects of the healthcare industry and his unique skillset enables him to author the development and delivery of successful responses to the new challenges posed by this rapidly changing environment.
Joe holds a PhD in behavioral science and a master’s degree in organizational improvement.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.